Alexium and Soft-Tex join forces

|

Published 15-APR-2020 11:06 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

In a significant commercial development for Alexium International Group Limited (ASX:AJX), the company has signed a supply agreement with Soft-Tex International, Inc. (Soft-Tex) to exclusively purchase Alexicool® phase change material (PCM) products for bedding systems based on Soft-Tex’s Reactex® technology.

Alexicool® is Alexium’s proprietary cost-effective chemical finish for fabrics that absorb heat while providing a cool-to-the-touch feel.

Designed for bedding fabrics to improve comfort, Alexicool® also provides a durable PCM finish at a practical cost, offering high heat capacity and wash durability while being halogen free.

The agreement with Soft-Tex is a significant step forward on the first two Key Growth Pillars outlined by management in its half-year result, and it is the completion of a key milestone for the commercialisation of “total mattress cooling systems”.

These growth pillars revolve around providing the company with a unique value proposition to offer its customers, while also differentiating itself from competitors in a market that is valued at the US$65 million in the US alone.

Soft-Tex to exclusively use Alexicool®

Under the agreement, Soft-Tex International will exclusively use Alexicool® products for top-of-bed and mattress applications.

Terms of exclusivity apply to both current and future PCM based products from Soft-Tex International.

The agreement has an initial two-year term and may be automatically renewed.

The agreement specifies the provisions for the commercial relationship, including pricing, supply capabilities, and Alexium’s analytical support for Soft-Tex International commercial efforts.

Alexium’s management has conducted due diligence on Soft-Tex International and its suppliers, and they are confident with the distribution plan established by Soft-Tex International.

Soft-Tex International, Inc. manufactures and distributes premium specialty sleep products.

The group is headquartered in Waterford, New York with have operations in Shanghai, China.

The company has maintained its position as a leader in the basic bedding arena for three decades by constantly incorporating the latest sleep technologies.

Complementary technologies that draw on each other’s market strengths

Commenting on the signing of this agreement, chief executive Bob Brookins said, “Alexium is excited to be taking this step forward with Soft-Tex as we are pleased to provide products and services based on our advanced materials sciences capabilities.”

Alexium Chief Commercial Officer, Allen Reihman highlighted the complementary nature of the two companies technologies in saying, “This agreement formalizes the innovation partnership between Soft-tex and Alexium, combining the technology and market strengths of both companies.

‘’ReactexTM technology controls heat energy flow and storage to create a customer’s unique ideal personal bedding climate.

‘’Our Alexicool® products uniquely meet Soft-Tex requirements and provide the cooling engine for ReactexTM technology”.

Soft-Tex International is an innovation company focused on building the most comfortable products to help the world sleep and live better with its ReactexTM technologies spanning categories like personal climate control, wellness, antimicrobials and more.

The company has business relationships with some of the world’s most recognizable retailers including Bed Bath & Beyond, Amazon, J.C. Penney and Dillard’s.

Soft-Tex’s Chief Innovation Officer, Mark Smiderle added, “We chose Alexium as an innovation partner because they provide advanced PCM products, technical support, and analytical expertise that enable ReactexTM technology’s thermal regulation advantages.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X